Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elizabeth A Morgan

Showing results (1-10 of 77) with videos related to

Pageof 8
Sort By:
American Journal of Obstetrics & Gynecology MFM|August 25, 2020
Why "good enough" is not good enough: scientific data, not supply chain deficiencies, should be driving Centers for Disease Control and Prevention recommendationsElizabeth A Morgan, Diana Rodríguez
Advances in Hematology|April 5, 2012
Anaplastic lymphoma kinase-positive large B-cell lymphoma: an underrecognized aggressive lymphomaElizabeth A Morgan, Alessandra F Nascimento
Molecular and Cellular Biology|August 23, 2002
The requirement for ATP hydrolysis by Saccharomyces cerevisiae Rad51 is bypassed by mating-type heterozygosity or RAD54 in high copyElizabeth A Morgan, Naseem Shah, Lorraine S Symington
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 26, 2006
Skeletal complications of breast cancer therapiesAngela Hirbe, Elizabeth A Morgan, Ozge Uluçkan, et al.
Cardiovascular Pathology : the Official Journal of the Society for Cardiovascular Pathology|June 12, 2016
Case report and literature review: cardiac tamponade as a complication of pericardial extramedullary hematopoiesisNavin R Mahadevan, Elizabeth A Morgan, Richard N Mitchell
Human Pathology|May 29, 2017
T-cell transcription factor GATA-3 is an immunophenotypic marker of acute leukemias with T-cell differentiationDavid M Dorfman, Elizabeth A Morgan, Ashley Pelton, et al.
American Journal of Clinical Pathology|January 29, 2013
Immunohistochemical detection of hairy cell leukemia in paraffin sections using a highly effective CD103 rabbit monoclonal antibodyElizabeth A Morgan, Hongbo Yu, Jack L Pinkus, et al.
American Journal of Obstetrics and Gynecology|July 26, 2019
The effect of placental location in cases of placenta accreta spectrumElizabeth A Morgan, Abbey Sidebottom, Marc Vacquier, et al.
Histopathology|November 21, 2012
PAX8 and PAX5 are differentially expressed in B-cell and T-cell lymphomasElizabeth A Morgan, Olga Pozdnyakova, Alessandra F Nascimento, et al.
Journal of Cutaneous Pathology|July 10, 2019
Variable loss of CD30 expression by immunohistochemistry in recurrent cutaneous CD30+ lymphoid neoplasms treated with brentuximab vedotinAmrita Goyal, Sanjay Patel, Kavita Goyal, et al.
Pageof 8

Showing results (1-10 of 77) with videos related to

Sort By:
Pageof 8
American Journal of Obstetrics & Gynecology MFM|August 25, 2020
Why "good enough" is not good enough: scientific data, not supply chain deficiencies, should be driving Centers for Disease Control and Prevention recommendationsElizabeth A Morgan, Diana Rodríguez
Advances in Hematology|April 5, 2012
Anaplastic lymphoma kinase-positive large B-cell lymphoma: an underrecognized aggressive lymphomaElizabeth A Morgan, Alessandra F Nascimento
Molecular and Cellular Biology|August 23, 2002
The requirement for ATP hydrolysis by Saccharomyces cerevisiae Rad51 is bypassed by mating-type heterozygosity or RAD54 in high copyElizabeth A Morgan, Naseem Shah, Lorraine S Symington
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 26, 2006
Skeletal complications of breast cancer therapiesAngela Hirbe, Elizabeth A Morgan, Ozge Uluçkan, et al.
Cardiovascular Pathology : the Official Journal of the Society for Cardiovascular Pathology|June 12, 2016
Case report and literature review: cardiac tamponade as a complication of pericardial extramedullary hematopoiesisNavin R Mahadevan, Elizabeth A Morgan, Richard N Mitchell
Human Pathology|May 29, 2017
T-cell transcription factor GATA-3 is an immunophenotypic marker of acute leukemias with T-cell differentiationDavid M Dorfman, Elizabeth A Morgan, Ashley Pelton, et al.
American Journal of Clinical Pathology|January 29, 2013
Immunohistochemical detection of hairy cell leukemia in paraffin sections using a highly effective CD103 rabbit monoclonal antibodyElizabeth A Morgan, Hongbo Yu, Jack L Pinkus, et al.
American Journal of Obstetrics and Gynecology|July 26, 2019
The effect of placental location in cases of placenta accreta spectrumElizabeth A Morgan, Abbey Sidebottom, Marc Vacquier, et al.
Histopathology|November 21, 2012
PAX8 and PAX5 are differentially expressed in B-cell and T-cell lymphomasElizabeth A Morgan, Olga Pozdnyakova, Alessandra F Nascimento, et al.
Journal of Cutaneous Pathology|July 10, 2019
Variable loss of CD30 expression by immunohistochemistry in recurrent cutaneous CD30+ lymphoid neoplasms treated with brentuximab vedotinAmrita Goyal, Sanjay Patel, Kavita Goyal, et al.
Pageof 8